|
| mTORC1 sustains vision in retinitis pigmentosa |
|
https://doi.org/10.18632/oncotarget.4466
Lolita Petit, and Claudio Punzo
|
| 16786-16787 |
|
| Specificity and diversity of the mouse Peyer’s patch mononuclear phagocyte system |
|
https://doi.org/10.18632/oncotarget.4481
Johnny Bonnardel, Clément Da Silva, and Hugues Lelouard
|
| 16788-16789 |
|
| Rejuvenation by inhibiting TGFβ1/pSmad signaling |
|
https://doi.org/10.18632/oncotarget.4563
Elizabeth H. Corder, and Karta Purkh Singh Khalsa
|
| 16790-16791 |
|
| The APC/C and CK1 in the developing brain |
|
https://doi.org/10.18632/oncotarget.4797
Clara Penas, Mary E. Hatten, and Nagi G. Ayad
|
| 16792-16793 |
|
| Aging phenomics enabled by quantitative imaging analysis |
|
https://doi.org/10.18632/oncotarget.4566
Weiyang Chen, and Jing-Dong J. Han
|
| 16794-16795 |
|
| The higherorder molecular organization of p62/SQSTM1 |
|
https://doi.org/10.18632/oncotarget.4590
Terje Johansen, and Carsten Sachse
|
| 16796-16797 |
|
| Infectious origins of childhood leukemia |
|
https://doi.org/10.18632/oncotarget.4630
Srividya Swaminathan, and Markus Müschen
|
| 16798-16799 |
|
| Mitochondriolus: assembling mitoribosomes |
|
https://doi.org/10.18632/oncotarget.4646
Antoni Barrientos
|
| 16800-16801 |
|
| IRX1 hypomethylation in osteosarcoma metastasis |
|
https://doi.org/10.18632/oncotarget.4696
Jinchang Lu, and Jin Wang
|
| 16802-16803 |
|
| LKB1 in transmembrane receptor signaling |
|
https://doi.org/10.18632/oncotarget.4777
Imoh S. Okon, and Ming-Hui Zou
|
| 16804-16805 |
|
| The MIOREX complex lean management of mitochondrial gene expression |
|
https://doi.org/10.18632/oncotarget.4783
Kirsten Kehrein, Braulio Vargas Möller-Hergt, and Martin Ott
|
| 16806-16807 |
|
| Geneticallyencoded sensors of protein hydrodynamics |
|
https://doi.org/10.18632/oncotarget.4785
Alexander Hoepker, Yuling Yan, and Gerard Marriott
|
| 16808-16809 |
|
| mTORtuous effect on the elastic heart |
|
https://doi.org/10.18632/oncotarget.4788
Jonathan C. Schisler, and Rosalind A. Coleman
|
| 16810-16811 |
|
| Redefining protein moonlighting |
|
https://doi.org/10.18632/oncotarget.4793
Charles E. Chapple, and Christine Brun
|
| 16812-16813 |
|
| Sirtuin 3 in acute kidney injury |
|
https://doi.org/10.18632/oncotarget.4794
Luca Perico, Giuseppe Remuzzi, and Ariela Benigni
|
| 16814-16815 |
|
| miR24 in diabetes |
|
https://doi.org/10.18632/oncotarget.4795
Yaozu Xiang
|
| 16816-16817 |
|
| Protein quality and quantity control at the yeast ER |
|
https://doi.org/10.18632/oncotarget.4855
Stefan G. Kreft
|
| 16818-16819 |
|
| Physiologically distinct neuronal type in primate cortex |
|
https://doi.org/10.18632/oncotarget.4796
Bo Wang, and Yousheng Shu
|
| 16820-16821 |
|
| Mps1Ndc80: one interaction to rule them all |
|
https://doi.org/10.18632/oncotarget.4837
Jakob Nilsson
|
| 16822-16823 |
|
| Plant immune receptors mimic pathogen virulence targets |
|
https://doi.org/10.18632/oncotarget.4838
Panagiotis F. Sarris, and Jonathan D.G. Jones
|
| 16824-16825 |
|
| Antimicrobial peptides target ribosomes |
|
https://doi.org/10.18632/oncotarget.4839
Daniel N. Wilson, Gilles Guichard, and C. Axel Innis
|
| 16826-16827 |
|
| DNA repair: Location location location |
|
https://doi.org/10.18632/oncotarget.4840
Marjolein van Sluis, and Brian McStay
|
| 16828-16829 |
|
| ETV6 mutations define a new cancer predisposition syndrome |
|
https://doi.org/10.18632/oncotarget.4842
Gregory Kirkpatrick, Leila Noetzli, Jorge Di Paola, and Christopher C. Porter
|
| 16830-16831 |
|
| Targeting cancer cell metabolism in pancreatic adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.4160
Romain Cohen, Cindy Neuzillet, Annemilaï Tijeras-Raballand, Sandrine Faivre, Armand de Gramont, and Eric Raymond
|
| 16832-16847 |
|
| Reactive oxygen species a doubleedged sword for mesothelioma |
|
https://doi.org/10.18632/oncotarget.4253
Serena Benedetti, Barbara Nuvoli, Simona Catalani, and Rossella Galati
|
| 16848-16865 |
|
| Circadian disruption and breast cancer: An epigenetic link |
|
https://doi.org/10.18632/oncotarget.4343
David Z. Kochan, and Olga Kovalchuk
|
| 16866-16882 |
|
| Brain development is impaired in cfos / mice |
|
https://doi.org/10.18632/oncotarget.4527
Fabiola N. Velazquez, César G. Prucca, Olivier Etienne, Diego S. D'Astolfo, David C. Silvestre, François D. Boussin, and Beatriz L. Caputto
|
| 16883-16901 |
|
| ErbB3 activation by NRG1β sustains growth and promotes vemurafenib resistance in BRAFV600E colon cancer stem cells CSCs |
|
https://doi.org/10.18632/oncotarget.4642
Pramudita R. Prasetyanti, Emily Capone, Daniela Barcaroli, Daniela D’Agostino, Silvia Volpe, Antonina Benfante, Sander van Hooff, Valentina Iacobelli, Cosmo Rossi, Stefano Iacobelli, Jan Paul Medema, Vincenzo De Laurenzi, and Gianluca Sala
|
| 16902-16911 |
|
| Cyclin E/Cdk2dependent phosphorylation of Mcl1 determines its stability and cellular sensitivity to BH3 mimetics |
|
https://doi.org/10.18632/oncotarget.4857
Gaurav S. Choudhary, Trinh T. Tat, Saurav Misra, Brian T. Hill, Mitchell R. Smith, Alexandru Almasan, and Suparna Mazumder
|
| 16912-16925 |
|
| Antitumoral effect of desmethylclomipramine in lung cancer stem cells |
|
https://doi.org/10.18632/oncotarget.4700
Lucilla Bongiorno-Borbone, Arianna Giacobbe, Mirco Compagnone, Adriana Eramo, Ruggero De Maria, Angelo Peschiaroli, and Gerry Melino
|
| 16926-16938 |
|
| SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells |
|
https://doi.org/10.18632/oncotarget.4760
Lianhua Piao, Takehiro Suzuki, Naoshi Dohmae, Yusuke Nakamura, and Ryuji Hamamoto
|
| 16939-16950 |
|
| Highthroughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von HippelLindau loss in renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.4773
Nicholas C. Wolff, Andrea PavÃa-Jiménez, Vanina T. Tcheuyap, Shane Alexander, Mridula Vishwanath, Alana Christie, Xian-Jin Xie, Noelle S. Williams, Payal Kapur, Bruce Posner, Renée M. McKay, and James Brugarolas
|
| 16951-16962 |
|
| p53 amplifies Tolllike receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways |
|
https://doi.org/10.18632/oncotarget.4435
Maria Shatz, Igor Shats, Daniel Menendez, and Michael A. Resnick
|
| 16963-16980 |
|
| A highthroughput kinome screen reveals serum/glucocorticoidregulated kinase 1 as a therapeutic target for NF2deficient meningiomas |
|
https://doi.org/10.18632/oncotarget.4858
Roberta L. Beauchamp, Marianne F. James, Patrick A. DeSouza, Vilas Wagh, Wen-Ning Zhao, Justin T. Jordan, Anat Stemmer-Rachamimov, Scott R. Plotkin, James F. Gusella, Stephen J. Haggarty, and Vijaya Ramesh
|
| 16981-16997 |
|
| Effects of eight weeks of aerobic interval training and of isoinertial resistance training on risk factors of cardiometabolic diseases and exercise capacity in healthy elderly subjects |
|
https://doi.org/10.18632/oncotarget.4031
Paolo Bruseghini, Elisa Calabria, Enrico Tam, Chiara Milanese, Eugenio Oliboni, Andrea Pezzato, Silvia Pogliaghi, Gian Luca Salvagno, Federico Schena, Roberto Pozzi Mucelli, and Carlo Capelli
|
| 16998-17015 |
|
| Deletion of Smad3 improves cardiac allograft rejection in mice |
|
https://doi.org/10.18632/oncotarget.4849
Ying-ying Wang, Hong Jiang, Yu-cheng Wang, Xiao-ru Huang, Jun Pan, Chen Yang, Zhang-fei Shou, Shi-long Xiang, Da-jin Chen, Hui-yao Lan, and Jiang-hua Chen
|
| 17016-17030 |
|
| A comprehensive study of the association between drug hepatotoxicity and daily dose liver metabolism and lipophilicity using 975 oral medications |
|
https://doi.org/10.18632/oncotarget.4400
Zuquan Weng, Kejian Wang, Haibo Li, and Qiang Shi
|
| 17031-17038 |
|
| Involvement of Ras GTPaseactivating protein SH3 domainbinding protein 1 in the epithelialtomesenchymal transitioninduced metastasis of breast cancer cells via the Smad signaling pathway |
|
https://doi.org/10.18632/oncotarget.3636
Hao Zhang, Yan Ma, Shenghua Zhang, Hong Liu, Hongwei He, Naren Li, Yuyan Gong, Shuangshuang Zhao, Jian-dong Jiang, and Rong-guang Shao
|
| 17039-17053 |
|
| Agerelated changes in monocytes exacerbate neointimal hyperplasia after vascular injury |
|
https://doi.org/10.18632/oncotarget.3881
Laisel Martinez, Camilo Gomez, and Roberto I. Vazquez-Padron
|
| 17054-17064 |
|
| Transcriptome profiling of esophageal squamous cell carcinoma reveals a long noncoding RNA acting as a tumor suppressor |
|
https://doi.org/10.18632/oncotarget.4185
Guifeng Wei, Huaxia Luo, Yu Sun, Jiagen Li, Liqing Tian, Wei Liu, Lihui Liu, Jianjun Luo, Jie He, and Runsheng Chen
|
| 17065-17080 |
|
| Melatonin antiproliferative effects require active mitochondrial function in embryonal carcinoma cells |
|
https://doi.org/10.18632/oncotarget.4012
Rute Loureiro, Silvia Magalhães-Novais, Katia A. Mesquita, Ines Baldeiras, Isabel S. Sousa, Ludgero C. Tavares, Ines A. Barbosa, Paulo J. Oliveira, and Ignacio Vega-Naredo
|
| 17081-17096 |
|
| MicroRNA analysis suggests an additional level of feedback regulation in the NFκB signaling cascade |
|
https://doi.org/10.18632/oncotarget.4005
Peter Mechtler, Ruchi Singhal, Julia V. Kichina, Jonathan E. Bard, Michael J. Buck, and Eugene S. Kandel
|
| 17097-17106 |
|
| Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth invasion and epithelialtomesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3672
Jia-Ji Lin, Tian-Zhi Zhao, Wen-Ke Cai, Yong-Xiang Yang, Chao Sun, Zhuo Zhang, Yu-Qiao Xu, Ting Chang, and Zhu-Yi Li
|
| 17107-17120 |
|
| SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation metastasissuppressor and pluripotency gene expression |
|
https://doi.org/10.18632/oncotarget.2736
Silvia Esposito, Marco V. Russo, Irma Airoldi, Maria Grazia Tupone, Carlo Sorrentino, Giulia Barbarito, Serena Di Meo, and Emma Di Carlo
|
| 17121-17134 |
|
| Improvement of DC vaccine with ALAPDT induced immunogenic apoptotic cells for skin squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.3529
Jie Ji, Zhixia Fan, Feifan Zhou, Xiaojie Wang, Lei Shi, Haiyan Zhang, Peiru Wang, Degang Yang, Linglin Zhang, Wei R. Chen, and Xiuli Wang
|
| 17135-17146 |
|
| The novel dual PI3K/mTOR inhibitor NVPBGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.3940
Carolina Simioni, Alice Cani, Alberto M. Martelli, Giorgio Zauli, Ayman A.M. Alameen, Simona Ultimo, Giovanna Tabellini, James A. McCubrey, Silvano Capitani, and Luca M. Neri
|
| 17147-17160 |
|
| 3’Phosphoadenosine 5’phosphosulfate synthase 1 PAPSS1 knockdown sensitizes nonsmall cell lung cancer cells to DNA damaging agents |
|
https://doi.org/10.18632/oncotarget.3635
Ada W. Y. Leung, Wieslawa H. Dragowska, Daniel Ricaurte, Brian Kwok, Veena Mathew, Jeroen Roosendaal, Amith Ahluwalia, Corinna Warburton, Janessa J. Laskin, Peter C. Stirling, Mohammed A. Qadir, and Marcel B. Bally
|
| 17161-17177 |
|
| Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K hnRNP K upon inhibition of mitogen/extracellular signalregulated kinase MEK in malignant melanoma cells |
|
https://doi.org/10.18632/oncotarget.3935
Stefan Eder, Andreas Lamkowski, Markus Priller, Matthias Port, and Konrad Steinestel
|
| 17178-17191 |
|
| Mitochondrial p53 phosphorylation induces Bakmediated and caspaseindependent cell death |
|
https://doi.org/10.18632/oncotarget.3780
Jinjing Wang, Wenhao Guo, Hang Zhou, Na Luo, Chunlai Nie, Xinyu Zhao, Zhu Yuan, Xinyu Liu, and Yuquan Wei
|
| 17192-17205 |
|
| YAP is a critical oncogene in human cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.4043
Tiemin Pei, Yuejin Li, Jiabei Wang, Huanlai Wang, Yingjian Liang, Huawen Shi, Boshi Sun, Dalong Yin, Jing Sun, Ruipeng Song, Shangha Pan, Yu Sun, Hongchi Jiang, Tongsen Zheng, and Lianxin Liu
|
| 17206-17220 |
|
| TRPM8 channel as a novel molecular target in androgenregulated prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.3948
Swapna Asuthkar, Kiran Kumar Velpula, Pia A. Elustondo, Lusine Demirkhanyan, and Eleonora Zakharian
|
| 17221-17236 |
|
| Insulin/IGF1PI3Kdependent nucleolar localization of a glycolytic enzyme – phosphoglycerate mutase 2 is necessary for proper structure of nucleolus and RNA synthesis |
|
https://doi.org/10.18632/oncotarget.4044
Agnieszka Gizak, Marcin Grenda, Piotr Mamczur, Janusz Wisniewski, Filip Sucharski, Jerzy Silberring, James A. McCubrey, Jacek R. Wisniewski, and Dariusz Rakus
|
| 17237-17250 |
|
| Pharmacogenomic analysis indicates potential of 15isoquinolinediol as a universal antiaging agent for different tissues |
|
https://doi.org/10.18632/oncotarget.3949
Mi Sung Park, Joon-Seok Choi, Wan Lee, Yoon Jung Yang, Juhee Kim, Gun-Joo Lee, Sang Soo Kim, Seong Hoon Park, Sung Chul Kim, and Jin Woo Choi
|
| 17251-17260 |
|
| Peritoneal tumor spread in serous ovarian cancerepithelial mesenchymal status and outcome |
|
https://doi.org/10.18632/oncotarget.3746
Katharina Auer, Anna Bachmayr-Heyda, Stefanie Aust, Nyamdelger Sukhbaatar, Agnes Teresa Reiner, Christoph Grimm, Reinhard Horvat, Robert Zeillinger, and Dietmar Pils
|
| 17261-17275 |
|
| Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis |
|
https://doi.org/10.18632/oncotarget.3640
Dong-Hui Shin, Ji-Hye Park, Jeong-Yeon Lee, Hee-Young Won, Ki-Seok Jang, Kyueng-Whan Min, Si-Hyong Jang, Jong-Kyu Woo, Seung Hyun Oh, and Gu Kong
|
| 17276-17290 |
|
| FGF23 promotes prostate cancer progression |
|
https://doi.org/10.18632/oncotarget.4174
Shu Feng, Jianghua Wang, Yiqun Zhang, Chad J. Creighton, and Michael Ittmann
|
| 17291-17301 |
|
| TLR9 signaling through NFκB/RELA and STAT3 promotes tumorpropagating potential of prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.4029
Dayson Moreira, Qifang Zhang, Dewan Md S. Hossain, Sergey Nechaev, Haiqing Li, Claudia M. Kowolik, Massimo D’Apuzzo, Stephen Forman, Jeremy Jones, Sumanta K. Pal, and Marcin Kortylewski
|
| 17302-17313 |
|
| The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway |
|
https://doi.org/10.18632/oncotarget.1168
Emma M. Smith, Lei Zhang, Brian A. Walker, Emma L. Davenport, Lauren I. Aronson, David Krige, Leon Hooftman, Alan H. Drummond, Gareth J. Morgan, and Faith E. Davies
|
| 17314-17327 |
|
| Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization |
|
https://doi.org/10.18632/oncotarget.4175
Sergey A. Dyshlovoy, Jessica Hauschild, Kerstin Amann, Ksenia M. Tabakmakher, Simone Venz, Reinhard Walther, Alla G. Guzii, Tatiana N. Makarieva, Larisa K. Shubina, Sergey N. Fedorov, Valentin A. Stonik, Carsten Bokemeyer, Stefan Balabanov, Friedemann Honecker, and Gunhild v. Amsberg
|
| 17328-17341 |
|
| Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes |
|
https://doi.org/10.18632/oncotarget.3944
Giovanna Maria Pierantoni, Andrea Conte, Cinzia Rinaldo, Mara Tornincasa, Raffaele Gerlini, Antonella Federico, Davide Valente, Enzo Medico, and Alfredo Fusco
|
| 17342-17353 |
|
| Prognostic role of IDH mutations in gliomas: a metaanalysis of 55 observational studies |
|
https://doi.org/10.18632/oncotarget.4008
Liang Xia, Bin Wu, Zhiquan Fu, Fang Feng, Enqi Qiao, Qinglin Li, Caixing Sun, and Minghua Ge
|
| 17354-17365 |
|
| MicroRNA125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway |
|
https://doi.org/10.18632/oncotarget.3953
Sushmita Bose Nandy, Arunkumar Arumugam, Ramadevi Subramani, Diego Pedroza, Keziah Hernandez, Edward Saltzstein, and Rajkumar Lakshmanaswamy
|
| 17366-17378 |
|
| Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3954
Dipeng Ou, Hao Yang, Dong Hua, Shuai Xiao, and Lianyue Yang
|
| 17379-17390 |
|
| Sp1driven upregulation of miR19a decreases RHOB and promotes pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.3975
Yonggang Tan, Hongzhuan Yin, Heying Zhang, Jun Fang, Wei Zheng, Dan Li, Yue Li, Wei Cao, Cheng Sun, Yusi Liang, Juan Zeng, Huawei Zou, Weineng Fu, and Xianghong Yang
|
| 17391-17403 |
|
| MiR3615p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing1 |
|
https://doi.org/10.18632/oncotarget.3744
Fei Ma, Hongjiang Song, Baoliang Guo, Yuxin Zhang, Yasheng Zheng, Chengchun Lin, Ying Wu, Guijie Guan, Ruihua Sha, Qingxin Zhou, Dejun Wang, Xinglu Zhou, Juan Li, and Xiaohui Qiu
|
| 17404-17416 |
|
| TATODDp53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkinmediated mitophagy |
|
https://doi.org/10.18632/oncotarget.4002
Rong Zheng, Qiwei Yao, Guozhu Xie, Shasha Du, Chen Ren, Yuxia Wang, and Yawei Yuan
|
| 17417-17429 |
|
| C/Dbox snoRNAderived RNA production is associated with malignant transformation and metastatic progression in prostate cancer |
|
https://doi.org/10.18632/oncotarget.4172
Elena S. Martens-Uzunova, Youri Hoogstrate, Anton Kalsbeek, Bas Pigmans, Mirella Vredenbregt-van den Berg, Natasja Dits, Søren Jensby Nielsen, Adam Baker, Tapio Visakorpi, Chris Bangma, and Guido Jenster
|
| 17430-17444 |
|
| HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and Tcell responses |
|
https://doi.org/10.18632/oncotarget.3641
Nancy M. Benight, Purnima K. Wagh, Glendon M. Zinser, Belinda E. Peace, William D. Stuart, Juozas Vasiliauskas, Peterson Pathrose, Sandra L. Starnes, and Susan E. Waltz
|
| 17445-17461 |
|
| CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome |
|
https://doi.org/10.18632/oncotarget.3958
Yi Huang, Chunling Ma, Qunyuan Zhang, Jian Ye, Fang Wang, Yanping Zhang, Pamela Hunborg, Mark A. Varvares, Daniel F. Hoft, Eddy C. Hsueh, and Guangyong Peng
|
| 17462-17478 |
|
| RhoE is required for contact inhibition and negatively regulates tumor initiation and progression |
|
https://doi.org/10.18632/oncotarget.4127
Marta Hernández-Sánchez, Enric Poch, Rosa M. Guasch, JoaquÃn Ortega, Inmaculada López-Almela, Ignacio Palmero, and Ignacio Pérez-Roger
|
| 17479-17490 |
|
| EGFR tyrosine kinase inhibitors promote procaspase8 dimerization that sensitizes cancer cells to DNAdamaging therapy |
|
https://doi.org/10.18632/oncotarget.3959
Yun-Tian Li, Xiao-Jun Qian, Yan Yu, Zhen-Hua Li, Rui-Yan Wu, Jiao Ji, Lin Jiao, Xuan Li, Peng-Fei Kong, Wen-Dan Chen, Gong-Kan Feng, Rong Deng, and Xiao-Feng Zhu
|
| 17491-17500 |
|
| Endothelial Rac1 is essential for hematogenous metastasis to the lung |
|
https://doi.org/10.18632/oncotarget.3766
Hongyi Yao, Wei Shi, Junsong Wu, Chengyun Xu, Jirong Wang, Yanan Shao, Ximei Wu, and Zhongmiao Zang
|
| 17501-17513 |
|
| The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma |
|
https://doi.org/10.18632/oncotarget.4239
Andrea Di Cristofori, Stefano Ferrero, Irene Bertolini, Gabriella Gaudioso, Maria Veronica Russo, Valeria Berno, Marco Vanini, Marco Locatelli, Mario Zavanone, Paolo Rampini, Thomas Vaccari, Manuela Caroli, and Valentina Vaira
|
| 17514-17531 |
|
| The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5 |
|
https://doi.org/10.18632/oncotarget.3947
Bo Han, Weilong Yao, You-Take Oh, Jing-Shan Tong, Shaohua Li, Jiusheng Deng, Ping Yue, Fadlo R. Khuri, and Shi-Yong Sun
|
| 17532-17542 |
|
| Wholeexome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns |
|
https://doi.org/10.18632/oncotarget.4028
Ingrid Cifola, Marta Lionetti, Eva Pinatel, Katia Todoerti, Eleonora Mangano, Alessandro Pietrelli, Sonia Fabris, Laura Mosca, Vittorio Simeon, Maria Teresa Petrucci, Fortunato Morabito, Massimo Offidani, Francesco Di Raimondo, Antonietta Falcone, Tommaso Caravita, Cristina Battaglia, Gianluca De Bellis, Antonio Palumbo, Pellegrino Musto, and Antonino Neri
|
| 17543-17558 |
|
| By downregulating TIAM1 expression microRNA329 suppresses gastric cancer invasion and growth |
|
https://doi.org/10.18632/oncotarget.2755
Zheng Li, Xin Yu, Yang Wang, Jianxiong Shen, William Ka Kei Wu, Jinqian Liang, and Fan Feng
|
| 17559-17569 |
|
| Aberrant activation of Wnt/βcatenin signaling drives proliferation of bone sarcoma cells |
|
https://doi.org/10.18632/oncotarget.4100
Changbao Chen, Meng Zhao, Aixian Tian, Xiaolin Zhang, Zhi Yao, and Xinlong Ma
|
| 17570-17583 |
|
| UXT a novel MDMXbinding protein promotes glycolysis by mitigating p53mediated restriction of NFκB activity |
|
https://doi.org/10.18632/oncotarget.3770
Min Qi, Suthakar Ganapathy, Weiqi Zeng, Jianglin Zhang, John B. Little, and Zhi-Min Yuan
|
| 17584-17593 |
|
| NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells |
|
https://doi.org/10.18632/oncotarget.4009
Rama P. Kotipatruni, Xuan Ren, Dinesh Thotala, and Jerry J. Jaboin
|
| 17594-17604 |
|
| Enzastaurin inhibits ABCB1mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status |
|
https://doi.org/10.18632/oncotarget.2889
Martin Michaelis, Florian Rothweiler, Nadine Löschmann, Mohsen Sharifi, Taravat Ghafourian, and Jindrich Cinatl Jr.
|
| 17605-17620 |
|
| Combined estrogenic and antiestrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms |
|
https://doi.org/10.18632/oncotarget.4184
Céline Gérard, Mélanie Mestdagt, Ekaterine Tskitishvili, Laudine Communal, Anne Gompel, Elisabete Silva, Jean-François Arnal, Françoise Lenfant, Agnès Noel, Jean-Michel Foidart, and Christel Péqueux
|
| 17621-17636 |
|
| AKAP4 is a circulating biomarker for nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3946
Kiranmai Gumireddy, Anping Li, David H. Chang, Qin Liu, Andrew V. Kossenkov, Jinchun Yan, Robert J. Korst, Brian T. Nam, Hua Xu, Lin Zhang, Ganepola A.P. Ganepola, Louise C. Showe, and Qihong Huang
|
| 17637-17647 |
|
| Attenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anticancer immune response |
|
https://doi.org/10.18632/oncotarget.3893
Barbara Chirullo, Serena Ammendola, Leonardo Leonardi, Roberto Falcini, Paola Petrucci, Claudia Pistoia, Silvia Vendetti, Andrea Battistoni, and Paolo Pasquali
|
| 17648-17660 |
|
| Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGFβ1pSmad3RBP2EcadherinSmad3 feedback circuit |
|
https://doi.org/10.18632/oncotarget.3756
Xiuming Liang, Jiping Zeng, Lixiang Wang, Li Shen, Xueping Ma, Shuyan Li, Yujiao Wu, Lin Ma, Xinyu Ci, Qing Guo, Mutian Jia, Haiyu Shen, Yundong Sun, Zhifang Liu, Shili Liu, Wenjuan Li, Han Yu, Chunyan Chen, and Jihui Jia
|
| 17661-17674 |
|
| CEMTDD: The database for elucidating the relationships among herbs compounds targets and related diseases for Chinese ethnic minority traditional drugs |
|
https://doi.org/10.18632/oncotarget.3789
Jian Huang, Yaxin Zheng, Wenxi Wu, Tao Xie, Hong Yao, Xiaobo Pang, Fuzhou Sun, Liang Ouyang, and Jinhui Wang
|
| 17675-17684 |
|
| The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1 |
|
https://doi.org/10.18632/oncotarget.3779
Chunyan Wang, Zhi Nie, Zhongmei Zhou, Hailin Zhang, Rong Liu, Jing Wu, Junying Qin, Yun Ma, Liang Chen, Shumo Li, Wenlin Chen, Fubing Li, Peiguo Shi, Yingying Wu, Jian Shen, and Ceshi Chen
|
| 17685-17697 |
|
| BET inhibitor OTX015 targets BRD2 and BRD4 and decreases cMYC in acute leukemia cells |
|
https://doi.org/10.18632/oncotarget.4131
Marie-Magdelaine Coudé, Thorsten Braun, Jeannig Berrou, Mélanie Dupont, Sibyl Bertrand, Aline Masse, Emmanuel Raffoux, Raphaël Itzykson, Marc Delord, Maria E. Riveiro, Patrice Herait, André Baruchel, Hervé Dombret, and Claude Gardin
|
| 17698-17712 |
|
| Identification and evaluation of network modules for the prognosis of basallike breast cancer |
|
https://doi.org/10.18632/oncotarget.4034
Robin M. Hallett, Jessica G. Cockburn, Brian Li, Anna Dvorkin-Gheva, John A. Hassell, and Anita Bane
|
| 17713-17724 |
|
| Regulation of VCP/p97 demonstrates the critical balance between cell death and epithelialmesenchymal transition EMT downstream of ER stress |
|
https://doi.org/10.18632/oncotarget.3918
Parag P. Shah, and Levi J. Beverly
|
| 17725-17737 |
|
| Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes |
|
https://doi.org/10.18632/oncotarget.3921
ChunLing Dai, ShaoLin Ma, Fang Wang, HongYun Zhao, XingPing Wu, ZhenCong Huang, ZheSheng Chen, Kenneth To, and LiWu Fu
|
| 17738-17752 |
|
| miR514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma |
|
https://doi.org/10.18632/oncotarget.3924
Mitchell S. Stark, Vanessa F. Bonazzi, Glen M. Boyle, Jane M. Palmer, Judith Symmons, Catherine M. Lanagan, Christopher W. Schmidt, Adrian C. Herington, Robert Ballotti, Pamela M. Pollock, and Nicholas K. Hayward
|
| 17753-17763 |
|
| Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/Tcell lymphoma nasal type |
|
https://doi.org/10.18632/oncotarget.3776
Seungbok Lee, Ha Young Park, So Young Kang, Seok Jin Kim, Jinha Hwang, Seungho Lee, Soo Heon Kwak, Kyong Soo Park, Hae Yong Yoo, Won Seog Kim, Jong-Il Kim, and Young Hyeh Ko
|
| 17764-17776 |
|
| Purification and identification of a polysaccharide from medicinal mushroom Amauroderma rude with immunomodulatory activity and inhibitory effect on tumor growth |
|
https://doi.org/10.18632/oncotarget.4397
Honghui Pan, Yuanyuan Han, Jiguo Huang, Xiongtao Yu, Chunwei Jiao, Xiaobing Yang, Preet Dhaliwal, Yizhen Xie, and Burton B. Yang
|
| 17777-17791 |
|
| Thioredoxin reductase: A novel independent prognostic marker in patients with hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3785
Chunyan Li, Yan Peng, Binglang Mao, and Kun Qian
|
| 17792-17804 |
|
| Loss of tumor suppressive microRNA31 enhances TRADD/NFκB signaling in glioblastoma |
|
https://doi.org/10.18632/oncotarget.4596
Rajani Rajbhandari, Braden C. McFarland, Ashish Patel, Magda Gerigk, G. Kenneth Gray, Samuel C. Fehling, Markus Bredel, Nicolas F. Berbari, Hyunsoo Kim, Margaret P. Marks, Gordon P. Meares, Tanvi Sinha, Jeffrey Chuang, Etty N. Benveniste, and Susan E. Nozell
|
| 17805-17816 |
|
| CCAR2/DBC1 is required for Chk2dependent KAP1 phosphorylation and repair of DNA damage |
|
https://doi.org/10.18632/oncotarget.4417
Martina Magni, Vincenzo Ruscica, Michela Restelli, Enrico Fontanella, Giacomo Buscemi, and Laura Zannini
|
| 17817-17831 |
|
| Ergosterol purified from medicinal mushroom Amauroderma rude inhibits cancer growth in vitro and in vivo by upregulating multiple tumor suppressors |
|
https://doi.org/10.18632/oncotarget.4026
Xiangmin Li, Qingping Wu, Yizhen Xie, Yinrun Ding, William W. Du, Mouna Sdiri, and Burton B. Yang
|
| 17832-17846 |
|
| ERCPinduced duodenal perforation successfully treated with endoscopic pursestring suture: a case report |
|
https://doi.org/10.18632/oncotarget.4079
Quanpeng Li, Jie Ji, Fei Wang, Xianxiu Ge, Junjie Nie, Boming Xu, Xiuhua Zhang, Guobing Jiang, and Lin Miao
|
| 17847-17850 |
